MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
49 hedge funds and large institutions have $30M invested in MedAvail Holdings, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 18 reducing their positions, and 9 closing their positions.
2,142% more call options, than puts
Call options by funds: $807K | Put options by funds: $36K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 51 → 49 (-2)
18% less capital invested
Capital invested by funds: $36.8M → $30M (-$6.76M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
67% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$9.05M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$30.8K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$27.8K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$25.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$385K |
| 2 |
EGP
Entrust Global Partners
New York
|
-$317K |
| 3 |
Morgan Stanley
New York
|
-$239K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$233K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$97.6K |
MDVL Hedge Fund Activity: Q1 2022 in Review
49 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q1 2022, worth a combined $30M — down 18% from $36.8M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MDVL and 7 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 6 added.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $9.05M. The largest seller was Russell Investments Group, exiting entirely with an estimated $385K sold.
- 49 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q1 2022, down from 51 in Q4 2021.
- Funds reported $30M of MedAvail Holdings, Inc. Common Stock stock for Q1 2022, down 18% quarter-over-quarter.
- 7 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q1 2022 and 9 closed out, a net change of -2 holders.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q1 2022 was Alyeska Investment Group, an estimated $9.05M added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q1 2022 was Russell Investments Group, an estimated $385K sold.
Based on aggregated 13F filings for Q1 2022.